This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Dr.r.pfleger Chemische Fabrik Gmbh. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Inventor Spotlight: Ulrich Schwantes
Introduction
Ulrich Schwantes, an innovative inventor based in Geisfeld, Germany, has made significant contributions to the field of pharmaceuticals. His work primarily focuses on developing compositions and methods that enhance the treatment of bladder and urinary dysfunctions.
Latest Patents
Schwantes holds a patent for the use of trospium chloride in a unique two-component system. This patent describes compositions of the anticholinergic agent trospium chloride that are suitable for localized administration. Specifically, the compositions are in the form of an aqueous solution with a pH value of 4.5 or greater, prepared just prior to administration. The patent also outlines methods for utilizing these compositions to treat dysfunctions of the bladder and urinary system through intravesical administration, providing innovative solutions for patients in need.
Career Highlights
Ulrich Schwantes is affiliated with Dr. R. Pfleger Chemische Fabrik GmbH, a reputable company in the pharmaceutical industry. His expertise in the medicinal application of anticholinergic agents reflected in his patent highlights his dedication to improving patient care in the field of urology.
Collaborations
Throughout his career, Schwantes has collaborated with notable colleagues such as Albert Schaupp and Manfred Stohrer. These partnerships have likely fostered an environment of shared innovation and collective advancement in research and development.
Conclusion
Ulrich Schwantes stands out as a key inventor in the realm of pharmaceutical advancements, particularly in the treatment of bladder dysfunctions. His innovative work and dedication to improving patient outcomes continue to inspire future developments in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile